DUBLIN--(BUSINESS WIRE)-- Research and Markets(http://www.researchandmarkets.com/research/b33f66/global_prostate_ca) has announced the addition of the "Global Prostate Cancer Therapeutics Market (2010 - 2020) (Opportunity Analysis, Pipeline Assessment & Market Forecast)" report to their offering.
Prostate cancer is the most frequently diagnosed cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer-related mortality in men. The prostate cancer market has a huge demand for new and novel drugs that address unmet needs such as improved survival time, less toxicity, increased progression free survival, increased effectiveness, and lower cost.
This report studies the market from 2005 to 2020 covering 21 major drugs categorized into four therapies; namely hormonal therapy, chemotherapy, immunotherapy, and targeted therapy. Out of the whole lot of 21 drugs, 13 are currently commercially available in the market and 8 in pipeline. Growing prostate cancer population (25% increase in the incidence of prostate cancer in mature countries and 40% increase in emerging countries, from 2010 to 2020) is an impetus for the growth of the market. This factor, along with increasing number of innovative drugs estimated to get launched in short-term future and increasing old age male population are driving the growth of the market at an expected CAGR of 9% from 2010 to 2020. In 2010, among the mature markets, the U.S. was the major contributor; accounting for 35% of the total sales of prostate cancer drugs and amongst the emerging countries, China contributed to the share of about 2% of the overall prostate cancer therapeutics market.
Key Topics Covered:
- Introduction
- Executive Summary
- Market Overview
- Market Dynamics
- Product Market
- Pipeline Drugs Market
- Geographical Analysis
- Competitive Landscape
- Company Profiles
For more information visit http://www.researchandmarkets.com/research/b33f66/global_prostate_ca
CONTACT:
Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
KEYWORDS:
INDUSTRY KEYWORDS: Health Pharmaceutical General Health
MEDIA:
| Logo |